Advisor Group Holdings, Inc. Mannkind Corp Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Mannkind Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 29,009 shares of MNKD stock, worth $172,023. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,009

Previous 40,082 27.63%

Holding current value

$172,023

Previous $209,000 12.92%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$5.01 - $6.7 $55,475 - $74,189	-11,073 Reduced 27.63%	29,009 $182,000
Q2 2024 Aug 13, 2024	SELL	$4.05 - $5.43 $84,033 - $112,667	-20,749 Reduced 34.11%	40,082 $209,000
Q1 2024 May 10, 2024	BUY	$3.25 - $5.27 $4,644 - $7,530	1,429 Added 2.41%	60,831 $275,000
Q4 2023 Feb 12, 2024	SELL	$3.34 - $4.29 $30,303 - $38,923	-9,073 Reduced 13.25%	59,402 $216,000
Q3 2023 Nov 13, 2023	BUY	$3.91 - $5.45 $23,491 - $32,743	6,008 Added 9.62%	68,475 $282,000
Q2 2023 Aug 21, 2023	SELL	$3.72 - $4.79 $171 - $220	-46 Reduced 0.07%	62,467 $254,000
Q2 2023 Aug 10, 2023	SELL	$3.72 - $4.79 $28,714 - $36,974	-7,719 Reduced 10.99%	62,513 $254,000
Q1 2023 May 12, 2023	SELL	$3.95 - $5.63 $16,195 - $23,083	-4,100 Reduced 5.52%	70,232 $287,000
Q4 2022 Feb 10, 2023	BUY	$3.02 - $5.37 $11,569 - $20,572	3,831 Added 5.43%	74,332 $391,000
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $7,774 - $11,309	2,600 Added 3.83%	70,501 $218,000
Q2 2022 Aug 10, 2022	BUY	$2.67 - $4.77 $2,162 - $3,863	810 Added 1.21%	67,901 $263,000
Q1 2022 May 04, 2022	SELL	$2.62 - $4.45 $50,081 - $85,061	-19,115 Reduced 22.17%	67,091 $1.05 Million
Q3 2021 Nov 05, 2021	BUY	$3.89 - $5.48 $1,711 - $2,411	440 Added 0.51%	86,206 $378,000
Q2 2021 Aug 02, 2021	SELL	$3.61 - $5.45 $81,661 - $123,284	-22,621 Reduced 20.87%	85,766 $467,000
Q1 2021 May 13, 2021	BUY	$3.14 - $6.14 $23,832 - $46,602	7,590 Added 7.53%	108,387 $434,000
Q4 2020 Feb 10, 2021	SELL	$1.79 - $4.04 $13,403 - $30,251	-7,488 Reduced 6.92%	100,797 $316,000
Q3 2020 Nov 12, 2020	BUY	$1.56 - $2.08 $9,420 - $12,561	6,039 Added 5.91%	108,285 $196,000
Q2 2020 Aug 14, 2020	BUY	$0.94 - $2.21 $5,978 - $14,055	6,360 Added 6.63%	102,246 $179,000
Q1 2020 May 18, 2020	BUY	$0.84 - $1.76 $80,544 - $168,759	95,886 New	95,886 $94,000

Others Institutions Holding MNKD

# of Institutions

245

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.53B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Mannkind Corp Transaction History